Visionflex Fpo [vfx] (VFX.AX) Stock Analysis & Winston Score
Visionflex is an Australian healthcare technology company that makes telehealth devices and software. Its main product is a connected medical examination device that lets doctors remotely check patients using tools like digital stethoscopes, cameras, and vital sign monitors. The company sells to hospitals, aged care facilities, and remote health clinics, primarily in Australia but with some international reach. Visionflex earns revenue by selling its hardware devices and charging software or platform fees for ongoing use. The company is small, with a market cap near zero, and its financials show it is spending significantly more than it earns — the negative gross and operating margins mean it loses money on every dollar of revenue. The key growth opportunity is the global push toward remote and rural healthcare delivery, but the main risk is that Visionflex must raise additional capital to survive while competing against larger, better-funded telehealth and medical device companies.
Winston Score: 26/100 — Below Average
Below-average fundamentals — multiple weak pillars.
- Quality: Weak (1/30)
- Growth: Good (10/20)
- Cash Flow: Weak (0/10)
- Stability: Mixed (4/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)
